Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Source: SeekingAlpha
2025-12-30 08:57:41 ET
Since my October article , Biogen Inc. ( BIIB ) stock has risen 18.4%, outperforming the S&P 500 [2.9% return] ( SPY ), as well as two "bellwethers" for the biotech investors, the iShares Biotechnology ETF [14%] ( IBB ) and VanEck Biotech ETF [10.1%] ( BBH )....
Read the full article on Seeking Alpha
For further details see:
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
PTC Therapeutics Inc.
NASDAQ: PTCT
PTCT Trading
-5.2% G/L:
$62.34 Last:
348,422 Volume:
$64.70 Open:
PTCT Latest News
March 03, 2026 10:11:53 am
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing
February 19, 2026 04:01:00 pm
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
PTCT Stock Data
$5,800,830,036
75,872,448
1.06%
134
N/A
Biotechnology & Life Sciences
Healthcare
US
Warren
